Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Ryder Names Chief Operating Officer and New Chief Financial Officer
-
JPMorganChase to Host Fourth-Quarter and Full-Year 2024 Earnings Call
-
Independence Realty Trust Announces Fourth Quarter 2024 Dividend
-
Netcapital Announces Second Quarter Fiscal 2025 Financial Results
-
Central Garden & Pet Announces Increase in Stock Repurchase Authorization
-
Streamline Health® Reports Fiscal Third Quarter 2024 Financial Results, Accelerates Anticipated Adjusted EBITDA Breakeven Timeline
-
Rithm Capital Corp. Declares Fourth Quarter 2024 Common and Preferred Dividends
-
BD Resolves Previously Disclosed SEC Investigation
-
Snow Appointed to First Citizens BancShares Board of Directors
-
Tarrytown Expocare Pharmacy Acquires Greater Boston Long Term Care Pharmacy
-
Maison Solutions Reports Second Quarter and Six-Month 2025 Financial Results
-
Grosvenor CPC I Inc. Announces Postponement of Annual General and Special Meeting to January 24, 2025
-
PACS ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP Notifies Investors of a Class Action Lawsuit Against PACS Group, Inc.
-
Regeneron Named to Dow Jones Sustainability World Index for Sixth Consecutive Year
-
CVB Financial Corp. Announces 141st Consecutive Quarterly Cash Dividend
-
PEL 90 – QatarEnergy Farm-In
-
Amentum Reports Fiscal Year 2024 Results and Affirms its Fiscal Year 2025 Guidance
-
TETRA TECHNOLOGIES, INC. INTRODUCES TETRA OASIS TOTAL DESALINATION SOLUTION (TETRA OASIS TDS) AND RESULTS FROM PERMIAN BASIN BENEFICIAL RE-USE PILOT
-
Knight Therapeutics Announces Filing of New Drug Submission for Qelbree® (viloxazine) in Canada
-
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
Steven Vondran joins Ameren board of directors
-
NEUBERGER BERMAN MUNICIPAL FUND ANNOUNCES MONTHLY DISTRIBUTION
-
Merck Provides Update on KeyVibe and KEYFORM Clinical Development Programs Evaluating Investigational Vibostolimab and Favezelimab Fixed-Dose Combinations with Pembrolizumab
-
Tenaya Therapeutics to Announce Initial Data from MyPEAK-1 Phase 1b/2 Clinical Trial of TN-201 Gene Therapy for MYBPC3-Associated Hypertrophic Cardiomyopathy on Tuesday, December 17, 2024
-
Mr. Cooper Group Adds Former Fannie Mae Executive and Industry Veteran Andrew Bon Salle to Board of Directors
-
Integrated Wellness Acquisition Corp Receives Delisting Notice from the New York Stock Exchange
-
Paramount Gold Announces the Voting Results of Its 2024 Annual General Meeting
-
Bannix Acquisition Corp. Announces Monthly Extension to Complete its Initial Business Combination
-
CNH announces Global Leadership Team changes
-
Aspen Group Reports Positive Cash from Operations Fiscal Year-to-Date
-
Bestow Named a Top 100 Financial Technology Company of 2024
-
The Lumistella Company's The Elf on the Shelf®: A Christmas Tradition Dominates Publisher's Weekly Bestseller Lists with 4 Titles in the Top 10
-
Leo P. Denault, Former Chairman and Chief Executive Officer of Entergy Corporation, to Join PG&E Boards of Directors
-
Ark Restaurants Announces Financial Results for the Fourth Quarter and Fiscal Year Ended 2024
-
La-Z-Boy Incorporated Board of Directors Elects Melinda Whittington as Chair, Michael Lawton as Lead Director
-
Ambient Scientific unveils first ever AI module powered by a coin cell battery
-
Ivy Fertility Physicians and Staff Shine at 2024 ASRM Conference Following a Year of Growth And Innovation
-
Enzo Biochem Reports First Quarter Fiscal Year 2025 Results and Provides a Company Update
-
Satellos Announces Overnight Marketed Public Offering of Common Shares
-
ROSEN, LEADING INVESTOR COUNSEL, Encourages $JENNER Purchasers to Secure Counsel Before Important Deadline in Securities Class Action
-
Great Elm Capital Corp. (“GECC”) Declares $0.05 Per Common Share Special Cash Distribution and Approves First Quarter 2025 Distribution of $0.37 Per Common Share
-
The Ohio State University Opens NuScale Power Energy Exploration (E2) Center
-
The GEO Group Announces $70 Million Investment in Expanding ICE Services Capabilities and New Corporate Reorganization
-
Cool Company Ltd. - Increase in Share Capital
-
Ellington Financial Inc. Completes First Securitization of Closed-End Second Mortgages
-
Bank of America Declares Preferred Stock Dividends for First Quarter 2025
-
Angel Oak Mortgage REIT, Inc. Participates in AOMT 2024-13, Bringing Its 2024 Total Securitization Volume to Over $850 Million
-
Ingevity elects Kevin Willis to its board of directors
-
Molina Healthcare Awarded Contracts to Serve Dual Eligible Populations in Michigan and Idaho
-
CareTrust REIT Announces Quarterly Dividend of $0.29 per Share

